Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinsons disease associated with GBA mutations, Fabry disease
Molecular Weight:
507.57
Purity:
99.92
CAS Number:
[1629063-80-4]
Formula:
C24H30FN3O6S
Target:
Glucosylceramide Synthase (GCS)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted